Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Freegold Intersects 3.62 g/t Au over 42m and 1.23 g/t Au over 170.7m (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(1118)
•••
Comment by Hempdocon Aug 05, 2020 3:52pm
145 Views
Post# 31368811

RE:RE:RE:RE:RE:Where are we now?

RE:RE:RE:RE:RE:Where are we now?
Quattro74 wrote:
Eoganacht wrote: Not exactly, no. But I don't think it will be systemically like photophrin.

goldn1 wrote:
Eog:

Do you know how TLD is applied in the lung cancer treatment? I wouldn't think they would be able to fill a lung the same way they fill a bladder right after a surgery? Depending upon how it is applied, this can be used for a lot of different cancer surgeries... Odd that Theralase is mum regarding the application of one of their compounds...


G1

 


Nothing more than a wild guess but I still think the Rutherrin could be applied via inhalation. Maybe through a nebulizer? Then after it has time to localize, in whatever cancer cells are left after the surgery, zapp the area with the Lumeda machine. ???  


Hi Quattro...more than likely they would approach the cancer via a guided intratumoral injection.  If not accessible by this route, IV is an option.  A nebulized treatment would not specifically target a peripheral or hard-to-reach cancer...much of any nebulized medications end up deposited in the upper airway, including the nose, mouth & throat.

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities